AKT1 and hepatocellular carcinoma: Through single-cell RNA sequencing on an HCC PDO, Zhao and colleagues exhibited that constitutive activation of downstream pathways such as PI3K-Akt might result in resistance to tyrosine kinase inhibitor (73).